Michael J. Pellini - 01 Jun 2021 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 21:45:58 UTC
Previous filing
26 May 2021
Next filing
22 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Conversion of derivative security +96,944 96,944 20 May 2021 By The Pellini Family Trust F1, F2
holding OMIC Common Stock 72,455 01 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Series A Preferred Stock Conversion of derivative security -96,944 -100% 0 20 May 2021 Common Stock 96,944 By The Pellini Family Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of the Series A Preferred Stock (the "Preferred Stock") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis. The shares of Preferred Stock had no expiration date.
F2 The Reporting Person is the trustee of The Pellini Family Trust and has voting and dispositive power with respect to these shares.